Head of Investor Relations
Vir Biotechnology, Inc. (VIR)Equibles does not estimate personal net worth.
Get an email with a short summary when Vir Biotechnology, Inc. publishes a filing, an earnings call transcript or a press release.
Get VIR alertsRich Lepke is recorded as Head of Investor Relations at Vir Biotechnology, Inc. (VIR). Rich Lepke has spoken on 4 earnings calls across 1 company, most recently for Vir Biotechnology, Inc. on August 6, 2025. Vir Biotechnology, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Vir Biotechnology, Inc. includes Marianne De Backer, MSc, Ph.D., MBA (CEO and Board Member), Aziz Sawaf (CFO), Brent Sabatini (CFO) and 7 others.
“With me today are Dr. Marianne DeBacker, our Chief Executive Officer, Dr. Mark Eisner, our Chief Medical Officer, Jason O'Byrne, our Chief Financial Officer, and Dr. Mika DeRink, our Executive Vice President of Oncology, who will be available during the Q&A session.”
“With me today are Dr. Marianne DeBacher, our Chief Executive Officer, Dr. Mark Eisner, our Chief Medical Officer, Jason O'Byrne, our Chief Financial Officer, and Dr. Mika DeRink, our Executive Vice President of Oncology, who will be available during the Q&A session.”
“With me today are Dr. Marianne DeBacher, our Chief Executive Officer, Dr. Mark Eidner, our Chief Medical Officer, Jason R. Byrne, our Chief Financial Officer, and Dr. Mika Dering, our Executive Vice President of Oncology, will be available during the Q&A session.”
“With me today are Dr. Marianne DeBacher, our Chief Executive Officer, Dr. Mark Eisner, our Chief Medical Officer, and Jason O'Byrne, our Chief Financial Officer.”
Biotechnology · Healthcare
Head of Investor Relations
